Latest Headlines

  1. Celebrating The Successful Launch Of Cryoport Systems' IntegriCell™ Cryopreservation Facility In Houston 10/22/2024

    On October 22, Cryoport Systems marked an exciting milestone with the official launch of our IntegriCell™ Cryopreservation facility at the Cryoport Supply Chain Campus in Houston.

  2. New York Blood Center Enterprises To Partner In Governor Hochul's Nation-Leading Cell And Gene Therapy Innovation Hub: New York Biogenesis Park 10/22/2024

    Governor Kathy Hochul yesterday announced plans for New York BioGenesis Park (NYBGP), a groundbreaking $430 million Cell and Gene Therapy (CGT) Innovation Hub that will position New York as a global leader in CGT research, development, and innovation.

  3. Join Avance Clinical At Biotech Showcase 2025 10/17/2024

    Avance Clinical, with over 30 years of experience as a leading full-service Contract Research Organization (CRO), is looking forward to once again meet with biotechs at Biotech Showcase 2025.

    With over 30 years of experience as a full-service Contract Research Organization (CRO) and known for our leading EARLY PHASE specialist clinical research in Australia, we are committed to delivering high-quality, compliant clinical trials.

  4. Join Avance Clinical At The CNS Summit 2024 10/17/2024

    Avance Clinical is thrilled to announce our participation in the CNS Summit 2024, taking place from November 10 – 13, 2024, in Boston, MA. The CNS Summit is a premier event dedicated to advancing clinical development and technology innovation in the Central Nervous System (CNS) therapeutic area. The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.

  5. 2024 KoNECT-MOHW-MFDS International Conference (KIC) Meet Avance in Seoul 10/17/2024

    Avance Clinical is proud to announce our attendance at the 2024 KoNECT-MOHW-MFDS International Conference (KIC) in Seoul, South Korea, October 29 – 31, 2024. As part of our commitment to expanding our global presence and strengthening our capabilities in the Asia-Pacific region, CEO Yvonne Lungershausen and Asia Regional Director Jessica Han will be attending the conference, meeting with biotech clients and partners to discuss opportunities in early and late-phase clinical trials.

  6. Avance Clinical Welcomes Kelly Yang As Associate Director, Operations Taiwan 10/17/2024

    Avance Clinical, a leading global contract research organization (CRO) specializing in advanced clinical research solutions for biotechs, is excited to announce the appointment of Kelly Yang as Associate Director, Operations Taiwan. Kelly brings over 15 years of experience in the pharmaceutical and clinical research industries, making her a valuable addition to Avance Clinical’s growing team.

  7. Germfree Acquires Cleanroom Wall And Ceiling OEM Arcoplast 10/15/2024

    Germfree, a pioneering leader in modular and mobile cleanroom infrastructure, equipment and services, today announced the acquisition of Arcoplast, maker of the leading seamless primary barrier cleanroom wall and ceiling system for Life Science applications and more. The acquisition will allow Germfree to offer comprehensive facility solutions from the ground up and follows 17 years of collaboration between the companies, during which Arcoplast has supplied architectural systems for Germfree installations at over 200 facilities globally.

  8. AST Announces Additions To Business Development Team 10/9/2024

    AST is pleased to welcome two new members to our business development team. Kacie Dennis (right) and Maximilian Kircher (left) joined our team last week and (literally) hit the ground running. They’re already en route to their first tradeshows with AST where, this week, Kacie will be in person at Meeting on the Mesa, and you can find Max in Italy at CPHI Worldwide.  

  9. Ascend Advanced Therapies Procures GENiSYS® C Isolated Filling Systems From AST For Gene Therapy Manufacturing 10/3/2024

    AST, a leading provider of flexible aseptic filling systems, has announced the placement of a next-generation GENiSYS® C fill-finish system at the Ascend Advanced Therapies (Ascend) Alachua, FL facility. Ascend is a global gene to GMP gene therapy development partner with 58,500 square feet of recently acquired GMP manufacturing space in Alachua, a rapidly growing biotech hub and birthplace of AAV gene therapy. The new fully automated and isolated filling and closing line will be installed as part of the commercial infrastructure expansion of the Ascend Alachua facility.

  10. CAI Appoints Sheena Dempsey As Chief Executive Officer 10/2/2024

    CAI, a global professional services firm and trailblazer in operational readiness and excellence, today announced Sheena Dempsey as Chief Executive Officer (CEO). Dempsey is a widely respected and highly accomplished C-Suite executive with more than 25 years of expertise in global business transformation, sales and operations, P&L management and creating and nurturing high performing teams. In this role, she will lead CAI as a global partner in its ongoing commitment to ensuring client operational readiness through innovative methodologies and technology.